Business Wire

Fresenius Kabi Introduces Bortezomib for Injection

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of Bortezomib for Injection. Fresenius Kabi Bortezomib for Injection is available as a single ...

Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...
Nasdaq

Dr. Reddy's Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
EurekAlert!

VELCADE® for injection receives EU marketing authorisation for second-line use in multiple myeloma

HIGH WYCOMBE, UK, 28th April 2005 – Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, today announced that the European Commission has approved the use of VELCADE® (bortezomib) for ...
FierceBiotech

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma

CAMBRIDGE, Mass. and OSAKA, Japan, June 20 /PRNewswire/ -- Millennium Pharmaceuticals, The Takeda Oncology Company, and Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) today announced that ...
FierceBiotech

Takeda to Co-Promote VELCADE® (bortezomib) for Injection in Japan

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (“Takeda,” TSE:4502) and its wholly owned subsidiary Millennium: The Takeda Oncology Company (“Millennium”) ...
ascopubs.org

Development and implementation of a home bortezomib injection program in the US (Ann Arbor VA Close to Me).

Modernizing clinical trial accessibility: Integrating the AI-powered LookUpTrials app into the CTN program. Nursing Lack of a protocol for home administration of bortezomib Educational materials, ...
News Medical

DBL Bortezomib Powder for Injection

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Bortezomib Powder for Injection contains the active ingredient ...
Reuters

Millennium Pharm Velcade for injection based therapies Produced Complete Remission Rates as High as 54%

Co reported on the presentation of results from clinical trials of Velcade based therapies that showed high complete remission / complete response rates in previously treated multiple myeloma patients ...
Medscape

International Approvals: Pegasys, Velcade, Alesion Dry Syrup 1%

Feb. 7, 2005 -- The European Commission has approved an expanded indication for peginterferon alfa-2a injection, allowing its use in the European Union for the treatment of hepatitis C virus in ...
Business Wire

Dr. Reddy's Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
The Financial

Takeda to Co-promote VELCADE (bortezomib) for Injection in Japan

The FINANCIAL — Takeda Pharmaceutical Company Limited (“Takeda,” TSE:4502) and its wholly owned subsidiary Millennium: The Takeda Oncology Company (“Millennium”) on May 10 announced that Takeda has ...